CRL Charles River Laboratories International, Inc.
CRL Charles River Laboratories International, Inc.
Healthcare · Diagnostics & Research
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 bull converging
POC $167.56 · VWAP $211.50 · +63.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, EVP + 4 others sold $14.3M, Aug 10–20
Coverage
1 watchlist
CRL Price Structure
Loading timeframes…
Peers
Every watchlist CRL belongs to, members best 30-day change first — CRL highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Decision history
1 scored call · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported the quarter ending 2026-06-27: revenue $1.00B, diluted EPS -$0.03, net income -$1M (SEC filing). Across the print the stock moved +13.4% (close before → first close after).
full note →Against street estimates
How CRL's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about CRL from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 1 day ago · Oct 22
- Charles River Laboratories International (NYSE:CRL) Sets New 1-Year High - Here's What Happened
- Charles River Laboratories International, Inc. (CRL) Stock Price, News, Quote & History - Yahoo Finance
- Charles River (CRL) Stock Charges Higher On Bullish Targets And AI Hype
- Anthropic Says It Turned an Adjusted Profit Ahead of Its Expected IPO - 24/7 Wall St.
- sec.gov
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
CRL research tape
78 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to CRL.
Vertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries